BCG

Indian Institute of Technology (IIT) Bombay has appointed former Tata Consultancy Services (TCS) CEO Rajesh Gopinathan as head- translational research and entrepreneurship and professor of practice, the premier institute said on Friday. A translational research centre to support transition of IP from lab to industry was created recently. The new position of head, translational research and entrepreneurship has been created to further accelerate these initiatives, said the institute.Elevate Your Tech Prowess with…

Generative artificial intelligence and its impact on jobs and employment has been a constant debate ever since the new technology sprang up. The educated estimate is that AI is going to make some jobs obsolete, but it will also create new opportunities. However, one particular aspect where not much research has taken place is how AI and humans working together can impact work. This changed with a recent study that monitored the employees of the Boston Consulting Group (BCG) to find out the compounding effect of an…

The international BRACE trial, investigating the BCG vaccine’s efficacy against COVID-19, has found it does not reduce healthcare workers’ risk of contracting the disease. Future studies will explore the vaccine’s influence on other infections and COVID-19 vaccine responses.The international BRACE trial, investigating the BCG vaccine’s efficacy against <span class="glossaryLink" aria-describedby="tt" data-cmtooltip="<div class=glossaryItemTitle>COVID-19</div><div…

Indian fintech market has received $29 billion in funding across 2,084 deals to date (January 2017-July 2022), gaining 14% share of the global funding and No 2 spot on the deal volume, a new report has said.India's Cagr in the fintech sector grew by 20 per cent, which was higher than that of the US, the UK, and China which witnessed a growth of 16%, 15%, and 105, respectively, according to 'State of the Fintech Union 2022' report by the Boston Consulting Group (BCG) and Matrix Partners India.With 7,460 fintech companies,…

When babies in the African countries of Guinea Bissau and Uganda were given the tuberculosis vaccine, something remarkable happened.Instead of the vaccine only protecting against the target bacteria – Myocbacterium tuberculosis – the tuberculosis vaccine offered broad protection against a range of unrelated infections, including respiratory infections and serious complications such as sepsis.  Australian researchers have now pinpointed the biological mechanism behind the off-target effects of the tuberculosis vaccine.The…

CHENNAI: Scientists at ICMR’s National Institute for Research in Tuberculosis in Chennai plan to initiate a study on BCG booster dose for kids and…